General use-results survey (plaque psoriasis)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2031250238

Enrollment

1800

Registered

2025-07-17

Start date

2025-07-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque psoriasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients using VTAMA for the first time for plaque psoriasis (2) Patients must provide informed consent before the start

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Incidence of onset of adverse drug reactions Skin symptoms at the application site (folliculitis, dermatitis contact, acne, etc.) Coadministration with existing treatments	—

Contacts

Public ContactPatient Safety and Pharmacovigilance Dept.

Shionogi & Co., Ltd.

DL_pms-pharma@shionogi.co.jp+81-80-1054-2168

Outcome results